Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $28.9800 (12.46%) ($25.7500 - $29.0700) on Mon. Nov. 2, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 6.15% (three month average) | | RSI | 50 | | Latest Price | $28.9800(12.46%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | ATRA advances 4% a day on average for past five trading days. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability)
XBI(59%) IBB(52%) ARKG(49%) IWO(48%) IWM(44%) | | Factors Impacting ATRA price | ATRA will decline at least -3.075% in a week (0% probabilities).
VIXM(-17%) TLT(-13%) UUP(-7%) UNG(-3%) SHY(-3%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -3.075% (StdDev 6.15%) | | Hourly BBV | 0 () | | Intraday Trend | 12.5% | | | | | |
|
| 5 Day Moving Average | $26.28(10.27%) | | 10 Day Moving Average | $0(0%) | | 20 Day Moving Average | $0(0%) | | To recent high | 0% | | To recent low | 21.4% | | Market Cap | $2.153b | | | | | | |
Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |